MarketPulse

stem cell therapy

5 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

Orthobiologics Market Set to Hit $9.5B by 2031 as Regenerative Medicine Surges

Global orthobiologics market projected to grow 43% to $9.52B by 2031, driven by rising osteoarthritis and regenerative therapy advancements.
JNJSYKMDTZBHBVS+1regenerative medicinestem cell therapy
GlobeNewswire Inc.GlobeNewswire Inc.··Biorestorative Therapies, Inc.

BioRestorative Therapies to Showcase Regenerative Skincare Tech at Major NYC Wellness Event

BioRestorative Therapies will exhibit at Be+Well Beauty and Wellness Show in NYC (March 8-10, 2026) to advance its BioCosmeceutical platform commercialization.
BRTXclinical developmentregenerative medicine
BenzingaBenzinga··Prnewswire

Brainstorm Cell Therapeutics Completes $2M February Fundraising Round

Brainstorm Cell Therapeutics raised $2M in February through private placement at $0.60/share. Funds support general operations, regulatory work, and Phase 3b trial preparations for ALS therapy NurOwn.
BCLIprivate placementcapital raise
BenzingaBenzinga··Prnewswire

Brainstorm Cell Raises $1M Through Private Placement Above Current Valuation

Brainstorm Cell raised $1M via private placement at $0.60/share, above market price. Funds support Phase 3b ALS therapy trials and regulatory efforts.
BCLIprivate placementstem cell therapy
GlobeNewswire Inc.GlobeNewswire Inc.··Na

BioRestorative Closes $5M Equity Offering to Fund Stem Cell Pipeline

BioRestorative raised $5M through equity offering to advance stem cell therapies, including BRTX-100 for spine disease and metabolic disorder research.
BRTXclinical trialsregenerative medicine